Navigation Links
Thomson Reuters Finds Increase in New Research for 'Neglected' Tropical Diseases
Date:6/19/2012

PHILADELPHIA, June 19, 2012 /PRNewswire/ -- The Intellectual Property & Science division of Thomson Reuters today announced the publication of a new study tracking the current status of research on neglected tropical diseases.  The Global Research Report Neglected Tropical Diseases analyzes research output across countries and fields from 1992-2011 and finds a two-fold increase in published literature focused on a group of diseases identified by the World Health Organization as underserved by public health services.  Despite these recent gains, however, the total research output is still significantly less than that of "first world" diseases.

(Photo: http://photos.prnewswire.com/prnh/20120619/NY26881-INFO )

Though the analysis finds that research output focused on neglected tropical diseases has doubled from roughly 2,500 papers in 1992 to well over 5,000 papers in 2011, these totals still pale in comparison to other diseases such as cancer (85,000 papers), HIV/AIDS (16,000 papers) and coronary artery disease (15,000 papers).  To put this in context, more than one billion people are infected with one or more neglected tropical diseases and more than half a million die each year from their infections, compared with ~35 million globally who are infected with HIV or the ~346 million afflicted with diabetes. 

"Amidst high profile debate over the effectiveness of global health initiatives such as U.S. President Obama's Emergency Plan for AIDS Relief (PEPFAR), it is important for policymakers to understand the full scope of current research into diseases that affect a disproportionate amount of the world's population," said Jonathan Adams, director, research & development, Thomson Reuters.  "Neglected tropical diseases affect more than one billion people around the world
'/>"/>

SOURCE Thomson Reuters
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
2. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
3. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
4. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
5. First, do no harm: Study finds danger in standard treatment for a serious lung disease
6. CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety
7. "AWAKEN" Survey Finds Only 50 Percent of Americans Understand Significant Health Impact of Narcolepsy, and Many Physicians Not Comfortable Diagnosing the Sleep Disorder
8. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
9. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
10. Physician-Friendly Coding and Compliance Tool Increases Accuracy and Documentation of Patient Charges
11. Albemarle to increase ibuprofen prices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... Research (A*STAR) and Switzerland,s Cytos Biotechnology ... dosed in a Phase 1 clinical trial with their H1N1 ... particle (VLP) technology. In this first Phase 1 clinical trial, ... its potential to protect against H1N1 influenza infection will be ...
(Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... III study will evaluate effects of otelixizumab, an investigational anti-CD3 ... ... secretion, CAMBRIDGE, Mass., April 9, 2008 ... development of novel,therapies for immune-mediated diseases, today announced that it is,proceeding ...
... Calif., April 9, 2008 ,Poniard Pharmaceuticals, Inc. (Nasdaq: ... today announced that data from a Phase 2 ... patients with small,cell lung cancer (SCLC) will be ... Lung Cancer Conference in Geneva, Switzerland. The presentation ...
Cached Medicine Technology:Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 2Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 3Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 4Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference 2Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference 3
(Date:5/19/2013)... Omaha, Nebraska is a city of diversity, economic ... of the lowest unemployment rates in the country. Forbes Magazine ... for Business and Careers and it consistently scores high on ... located in the nation and is a strong business leader ... of Editions TV are pleased to announce air ...
(Date:5/19/2013)... Chicago, IL (PRWEB) May 19, 2013 In ... Surge, LLC, E-dentist.com has announced the launch of an SEO ... help dentists get high rankings in Google. , http://www.e-dentists.com/ ... do not pay for the service until they see results. ... sites. The lead generation websites run by JD Media Surge, ...
(Date:5/19/2013)... The muscles in the human body ... one of the biggest and most significant nervous systems ... peripheral system comprises of peripheral nerves that reside outside ... ensure that the limbs and hands, as well as ... get damaged due to trauma or physical injury, their ...
(Date:5/19/2013)... California (PRWEB) May 19, 2013 Grinding ... than just losing sleep, or annoying your spouse. At ... report by CNY Central (“Snoring and Teeth Grinding Could ... type of teeth grinding can be hard to prevent. ... million Americans, and one of its symptoms is a ...
(Date:5/19/2013)... 6Webs.com is the leader in reviews ... are considering an alarm system can do a comparison ... security system providers online at 6Webs.com. Just recently finishing ... home security system companies, 6Webs.com currently is announcing ... home security companies before ranking the home security system ...
Breaking Medicine News(10 mins):Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2
... at Weill Cornell Medical College could prove a potent weapon ... called SS31, is able to cross the blood-brain barrier and ... damage. ,"In our experiments, we found that exposing ... a much smaller area of brain tissue being affected," says ...
... (WHO) has approved four new drugs manufactured by the Macleods ... one of the four would be used against some strains ... of these four medicines will reinforce efforts to scale up ... in a statement. ,The medicines are the first ...
... out that organically grown kiwifruit has more health benefits ... This study is reported in the SCI’s magazine Chemistry ... in January that consuming organic fruits was just a ... by Drs. Maria Amodio and Adel Kader, showed that ...
... up 21 community medical centres in 20 provinces. This is ... run by the state, many of which are overflowing with ... is also intended to bring improvements to medical services in ... has said that 13 centres will be built in the ...
... independent survey which was conducted in all mental health ... continue to remain in mixed wards//. This is much ... in 99% of hospitals. ,The healthcare commission ... sleeping accommodation or bathrooms with the opposite sex. This ...
... fatty acids docosahexaenoic acid (DHA) successfully reduced diastolic blood ... up previous results with higher doses. // ,"A ... likely to be of clinical significance with regard to ... lead author Hannah Theobald from King's College London. ...
Cached Medicine News:Health News:Antioxidant Molecule Could Help Minimize Stroke-Linked Brain Damage 2Health News:Indian Pharma Authorized to Market New Anti-TB Drugs 2Health News:organic kiwifruits promote health 2Health News:Hospital Projects to Take the Weight Off Overcrowded Ones 2Health News:Low-dose Omega-3 Linked to Lower Blood Pressure 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: